Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBurping is one of the most commonly reported digestive side effects of Mounjaro (tirzepatide). It tends to appear in the first few weeks of treatment, often after meals, and is directly linked to the way the medicine slows gastric emptying. For most people it settles as the body adjusts, though it can be persistent for some. Because these are prescription-only medicines, any side effects worth monitoring are part of the conversation your prescriber should be having with you from the start. Mounjaro's full side-effect profile is documented on the NHS tirzepatide medicines page, which is a useful reference alongside your Patient Information Leaflet.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on Mounjaro for two or three weeks, you've had a fairly normal meal, and now you're sitting at your desk bringing up air every few minutes. It's embarrassing, slightly uncomfortable, and not what anyone mentioned before you started. The short answer is that it's a predictable consequence of how tirzepatide works.
Mounjaro activates both GIP and GLP-1 receptors, the two gut-hormone pathways involved in appetite regulation and blood-sugar control. One effect of this is that food moves through your stomach more slowly than usual, a process called delayed gastric emptying. When digestion slows, gas produced during that process has longer to accumulate, and the result is bloating and, yes, burping. It's not a sign the medicine is failing or that something has gone wrong. It's a direct, documented consequence of the mechanism.
The full Mounjaro side-effect profile covers a range of GI symptoms (nausea, constipation, indigestion) and burping sits squarely within that group. The symptom tends to be most noticeable in the days after starting or after a dose step up, when the effect on gastric motility is sharpest. For a broader look at tirzepatide as a treatment, the Mounjaro overview page covers eligibility, how it works and what to expect from the first pen onwards.
Timing varies between people, but the pattern is fairly consistent. The first few days at each dose are usually the peak. By the end of the first two weeks at a given dose, the majority of people find GI symptoms (including excessive burping) have settled to a manageable level or disappeared. If you're still burping heavily at week four without any sign of improvement, that's worth raising with your prescriber before moving to the next dose.
Certain habits reliably make it worse. Eating quickly traps more air. Carbonated drinks (fizzy water included) add directly to the gas load. Large meals compound the slow-emptying problem because more food sits in the stomach for longer. Fatty or heavily processed meals tend to linger longer than lighter ones, amplifying the effect. Coffee and alcohol can irritate the upper GI tract and trigger belching independently.
Some people find the burping is linked specifically to tirzepatide's effect at a particular dose and then largely disappears once the body has had four weeks to adapt, only to return briefly at the next step up. That repeating pattern is documented on our tirzepatide burping page, alongside reader questions our prescribers field regularly. If fatigue is also an issue alongside the GI symptoms, there's a separate practical guide on managing Mounjaro fatigue that covers the overlap.
You probably don't need a list of exotic remedies. The things that help are ordinary and evidence-consistent with what GI specialists recommend for gas-related symptoms generally: eat slowly, chew thoroughly, avoid gulping drinks. Keep meals smaller and more frequent rather than two or three large ones. Cut carbonated drinks for the first few weeks of each dose increase, then reintroduce if you want to. Sit upright for at least thirty minutes after eating, lying down slows things further.
Peppermint tea has a reasonable evidence base for general GI discomfort and is safe alongside tirzepatide for most people, though check with your prescriber if you're also taking other medicines. Simethicone-based over-the-counter products (available from most pharmacists) can help with trapped gas, but again, run it past your prescriber or pharmacist first. A more detailed breakdown of techniques, including meal timing and food choices that tend to reduce air swallowing, is covered in the practical guide to stopping burping on Mounjaro.
One thing our prescribers hear fairly often is that people assume the burping will continue at the same intensity throughout the whole course of treatment, and if you want a closer look at why it happens in the first place, our dedicated page on Mounjaro burping explains the underlying causes and what to expect at each stage. The tablet before the kettle goes on in the morning is a good metaphor for how to think about Mounjaro's GI effects: front-loaded, habitual once you've adjusted, and much quieter after the first few weeks.
Ordinary burping after meals is not dangerous. It is, however, worth knowing what would push this into different territory. Severe, persistent pain in your abdomen, particularly pain that radiates through to your back and comes with vomiting, is not a burping side effect, it's a potential sign of pancreatitis, which is a known but infrequent risk with GLP-1 medicines. The MHRA issued specific guidance on this in January 2026, and the message is clear: don't wait to see if it passes. Get medical help promptly.
Other symptoms worth acting on quickly include: signs of a severe allergic reaction (swelling of the face, lips or throat, difficulty breathing), gallbladder symptoms (sharp upper-right abdominal pain, particularly after eating), or significant dehydration from persistent vomiting or diarrhoea. These are not the same as burping and bloating and should never be managed at home with adjustments to meal size.
For anything that feels unusual or that isn't settling, contact your prescriber or GP. You can also report suspected side effects to the MHRA using the Yellow Card scheme, this applies both to clinical side effects and to concerns about the medicine's source or packaging. If you're wondering whether symptoms you're experiencing are in the expected range, our FAQs cover common questions, or you can reach us directly through the contact page. Our prescribers discuss side effects as part of every consultation, if you haven't started yet, a free consultation is the place to begin that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.